Published in EMBO J on April 01, 1994
Arabidopsis LTPG is a glycosylphosphatidylinositol-anchored lipid transfer protein required for export of lipids to the plant surface. Plant Cell (2009) 1.51
Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol (1996) 1.35
K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J Cell Biol (1995) 1.26
Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor. Am J Physiol Cell Physiol (2006) 1.11
Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains. Mol Ther (2012) 0.91
Glucose-induced sequential processing of a glycosyl-phosphatidylinositol-anchored ectoprotein in Saccharomyces cerevisiae. Mol Cell Biol (1996) 0.90
Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells. Clin Exp Immunol (1998) 0.89
Intracellular cleavage of glycosylphosphatidylinositol by phospholipase D induces activation of protein kinase Calpha. Biochem J (1999) 0.88
Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J Clin Immunol (1997) 0.88
Effects of membrane cholesterol depletion and GPI-anchored protein reduction on osteoblastic mechanotransduction. J Cell Physiol (2011) 0.86
GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy. Clin Exp Metastasis (2002) 0.85
Effect of glycosylphosphatidylinositol (GPI)-phospholipase D overexpression on GPI metabolism. Biochem J (2004) 0.84
Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C. Biochem J (1997) 0.84
Streptolysin-O induces release of glycosylphosphatidylinositol-anchored alkaline phosphatase from ROS cells by vesiculation independently of phospholipase action. Biochem J (1995) 0.82
GPI-AP release in cellular, developmental, and reproductive biology. J Lipid Res (2015) 0.80
Brefeldin A inhibits the endocytosis of plasma-membrane-associated heparan sulphate proteoglycans of cultured rat ovarian granulosa cells. Biochem J (1995) 0.80
Tolerance of glycosylphosphatidylinositol (GPI)-specific phospholipase D overexpression by Chinese hamster ovary cell mutants with aberrant GPI biosynthesis. Biochem J (2002) 0.79
Decay-accelerating factor (DAF) in stool specimens as a marker of disease activity in patients with ulcerative colitis (UC). Clin Exp Immunol (1998) 0.79
Endogenous glycosylphosphatidylinositol-specific phospholipase C releases renal dipeptidase from kidney proximal tubules in vitro. Biochem J (2001) 0.78
Subcellular distribution of glycosylphosphatidylinositol-specific phospholipase D in rat liver. Biochem J (1996) 0.78
Roles of CD48 in regulating immunity and tolerance. Clin Immunol (2016) 0.78
Proteomic Analysis of Non-depleted Serum Proteins from Bottlenose Dolphins Uncovers a High Vanin-1 Phenotype. Sci Rep (2016) 0.75
Phosphatidylinositol-glycan-phospholipase D is involved in neurodegeneration in prion disease. PLoS One (2015) 0.75
Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem (1981) 26.33
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell (1991) 8.99
Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu Rev Biochem (1988) 7.57
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med (1984) 5.47
Glycolipid anchoring of plasma membrane proteins. Annu Rev Cell Biol (1990) 3.88
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med (1985) 3.33
Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol (1989) 3.20
The glycosyl-phosphatidylinositol anchor of membrane proteins. Biochim Biophys Acta (1989) 3.13
Growth factor-like action of phosphatidic acid. Nature (1986) 2.87
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med (1987) 2.86
Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol (1988) 2.84
Receptor-mediated endocytosis. Biochem J (1985) 2.73
Multiple targets for brefeldin A. Cell (1991) 2.60
The axonal glycoprotein TAG-1 is an immunoglobulin superfamily member with neurite outgrowth-promoting activity. Cell (1990) 2.36
Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol (1991) 2.35
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Glycophospholipid membrane anchor attachment. Molecular analysis of the cleavage/attachment site. J Biol Chem (1991) 1.97
Fatty acid remodeling: a novel reaction sequence in the biosynthesis of trypanosome glycosyl phosphatidylinositol membrane anchors. Cell (1990) 1.83
Retracted Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. Nature (1993) 1.81
A phospholipase C from Trypanosoma brucei which selectively cleaves the glycolipid on the variant surface glycoprotein. J Biol Chem (1986) 1.67
A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc Natl Acad Sci U S A (1988) 1.54
Stromal cell associated haemopoiesis. J Cell Physiol Suppl (1982) 1.52
A glycan-phosphatidylinositol-specific phospholipase D in human serum. Science (1987) 1.50
Monensin inhibits recycling of macrophage mannose-glycoprotein receptors and ligand delivery to lysosomes. Biochem J (1984) 1.45
Identification of amine components in a glycolipid membrane-binding domain at the C-terminus of human erythrocyte acetylcholinesterase. Biochemistry (1986) 1.41
Biosynthesis, membrane association, and release of N-CAM-120, a phosphatidylinositol-linked form of the neural cell adhesion molecule. J Cell Biol (1987) 1.36
Phosphatidic acid that accumulates in platelet-derived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal. J Biol Chem (1992) 1.26
Primary structure and functional activity of a phosphatidylinositol-glycan-specific phospholipase D. Science (1991) 1.22
Dynamics and longevity of the glycolipid-anchored membrane protein, Thy-1. J Cell Biol (1990) 1.21
Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood (1993) 1.19
Drosophila fasciclin I, a neural cell adhesion molecule, has a phosphatidylinositol lipid membrane anchor that is developmentally regulated. J Biol Chem (1990) 1.18
Colworth Medal Lecture. Glycosyl-phosphatidylinositol membrane anchors: the tale of a tail. Biochem Soc Trans (1992) 1.17
Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J Immunol (1992) 1.17
"Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science (1990) 1.17
Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells. J Immunol (1989) 1.13
Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J Cell Biol (1991) 1.13
Purification of a glycosyl-phosphatidylinositol-specific phospholipase D from human plasma. J Biol Chem (1989) 1.11
Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes. J Immunol (1986) 1.09
Purification and characterization of glycosyl-phosphatidylinositol-specific phospholipase D. J Biol Chem (1990) 1.07
Spontaneous incorporation of the glycosyl-phosphatidylinositol-linked protein Thy-1 into cell membranes. Proc Natl Acad Sci U S A (1992) 1.07
Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. Biochem J (1991) 1.00
Partial characterization of the cross-reacting determinant, a carbohydrate epitope shared by decay accelerating factor and the variant surface glycoprotein of the African Trypanosoma brucei. J Immunol (1988) 0.98
Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood (1991) 0.97
Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins. Eur J Biochem (1992) 0.97
Characterization of soluble vs membrane-bound human placental 5'-nucleotidase. Biochem Biophys Res Commun (1990) 0.93
The conversion of the human membrane-associated folate binding protein (folate receptor) to the soluble folate binding protein by a membrane-associated metalloprotease. J Biol Chem (1991) 0.92
A soluble form of the F3 neuronal cell adhesion molecule promotes neurite outgrowth. J Cell Biol (1992) 0.90
Characterization of a hydrophilic form of Thy-1 purified from human cerebrospinal fluid. J Biol Chem (1988) 0.88
The synthesis and turnover of 5'-nucleotidase in primary cultured hepatocytes. Biochim Biophys Acta (1987) 0.88
Detection of a phosphatidylinositol-specific phospholipase C at the surface of Swiss 3T3 cells and its potential role in the regulation of cell growth. J Biol Chem (1990) 0.88
Production of the glycosylphosphatidylinositol-specific phospholipase D by the islets of Langerhans. J Biol Chem (1991) 0.87
Decay-accelerating factor (DAF): a review of its function and structure. Acta Med Scand Suppl (1987) 0.85
Isolation of decay accelerating factor (DAF) by a two-step procedure and determination of its N-terminal sequence. J Immunol Methods (1987) 0.85
Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood (1993) 0.84
New insights into the regulation of megakaryocytopoiesis by haematopoietic and fibroblastic growth factors and transforming growth factor beta 1. Br J Haematol (1992) 0.81
Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro. Int J Cell Cloning (1991) 0.80
An STS-based map of the human genome. Science (1995) 17.72
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med (1998) 6.83
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem (1994) 6.31
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol (1989) 4.57
Biology and biochemistry of proteinases in tumor invasion. Physiol Rev (1993) 4.17
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology (1993) 3.98
Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science (1986) 3.92
Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. J Exp Med (1986) 3.68
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature (1987) 3.62
Biological roles of fibroblast growth factor-2. Endocr Rev (1997) 3.57
A glycophospholipid membrane anchor acts as an apical targeting signal in polarized epithelial cells. J Cell Biol (1989) 3.56
Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell (1986) 3.42
Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol (1988) 3.16
Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol (1998) 3.12
The folding mechanism of a beta-sheet: the WW domain. J Mol Biol (2001) 3.00
Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol (1993) 2.90
Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol (1988) 2.84
Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int (1997) 2.82
Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol (1988) 2.69
Concept for easy fiberoptic intubation via a laryngeal airway mask. Anesth Analg (1999) 2.67
Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol (1999) 2.65
Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol (1990) 2.65
Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci U S A (1986) 2.62
Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA (1998) 2.60
Signal for attachment of a phospholipid membrane anchor in decay accelerating factor. Science (1987) 2.59
Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg Am (1999) 2.49
An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet (2000) 2.36
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol (1982) 2.33
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest (2000) 2.32
Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A (1991) 2.27
Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell (1998) 2.26
Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res (1999) 2.21
Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J (2000) 2.11
Endocytosis of glycophospholipid-anchored and transmembrane forms of CD4 by different endocytic pathways. EMBO J (1992) 2.09
Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol (1992) 2.08
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol (1989) 2.05
Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest. J Biol Chem (1997) 2.05
The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol (1987) 2.04
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
Filgrastim (r-metHuG-CSF): the first 10 years. Blood (1996) 1.99
Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol (1997) 1.98
Glycophospholipid membrane anchor attachment. Molecular analysis of the cleavage/attachment site. J Biol Chem (1991) 1.97
Adaptive electric field control of epileptic seizures. J Neurosci (2001) 1.96
Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol (1986) 1.94
TGF-beta latency: biological significance and mechanisms of activation. Stem Cells (1997) 1.91
Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol (1986) 1.91
Transformation of rat embryo fibroblasts by cloned polyoma virus DNA fragments containing only part of the early region. Proc Natl Acad Sci U S A (1980) 1.89
Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med (1974) 1.88
Heparan sulfate proteoglycans from mouse mammary epithelial cells: localization on the cell surface with a monoclonal antibody. J Cell Biol (1985) 1.88
Complex roles of Stat1 in regulating gene expression. Oncogene (2000) 1.87
Initial evaluation and management of upper airway injuries in trauma patients. J Clin Anesth (1991) 1.86
[Compartmental dispersion of enzymes in rat liver mitochondria]. Eur J Biochem (1968) 1.86
Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry (1982) 1.85
Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta (1988) 1.82
Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol (1999) 1.80
Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med (1990) 1.80
Glycosylphosphatidylinositol-anchored proteins are preferentially targeted to the basolateral surface in Fischer rat thyroid epithelial cells. J Cell Biol (1993) 1.78
Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population. Am J Gastroenterol (2001) 1.77
Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol (1990) 1.75
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol (1993) 1.71
Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol (1988) 1.69
A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun (1987) 1.69
Cloned mouse ribonucleotide reductase subunit M1 cDNA reveals amino acid sequence homology with Escherichia coli and herpesvirus ribonucleotide reductases. J Biol Chem (1985) 1.68
Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule. J Biol Chem (1980) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol (1993) 1.66
Curricular trends in instruction of pathology: a nationwide longitudinal study from 1993 to present. Hum Pathol (2001) 1.65
Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem (1995) 1.65
Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res (1990) 1.59
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem (1994) 1.58
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Vectorial apical delivery and slow endocytosis of a glycolipid-anchored fusion protein in transfected MDCK cells. Proc Natl Acad Sci U S A (1990) 1.56
Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology (1997) 1.56
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A (2001) 1.54
Varicella-zoster virus glycoprotein I is essential for growth of virus in Vero cells. J Virol (1997) 1.54
Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii. Biochemistry (2001) 1.54
Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci U S A (1991) 1.52
A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci U S A (1994) 1.52
Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol (1995) 1.52
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer. J Infect Dis (1994) 1.50
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology (1971) 1.49
Molecular species of plasminogen activators secreted by normal and neoplastic human cells. Cancer Res (1980) 1.49
Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest (1989) 1.48
Tumor promoters induce changes in the chick embryo fibroblast cytoskeleton. Cell (1979) 1.47
Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol (1996) 1.46
Glyceryl trinitrate ointment for the treatment of chronic anal fissure: results of a placebo-controlled trial and long-term follow-up. Dis Colon Rectum (1999) 1.46
Glucose turnover values in the dog obtained with various species of labeled glucose. Am J Physiol (1975) 1.45
Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression. J Biol Chem (1994) 1.45
Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res (1995) 1.43